chr19-19320880-AGCGGCCCAGGCGGCG-A
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 2P and 10B. PM4BP6_ModerateBS1BS2
The NM_015329.4(MAU2):c.33_47delGGCGGCGGCCCAGGC(p.Ala12_Ala16del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.0133 in 1,516,008 control chromosomes in the GnomAD database, including 167 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0094 ( 16 hom., cov: 33)
Exomes 𝑓: 0.014 ( 151 hom. )
Consequence
MAU2
NM_015329.4 disruptive_inframe_deletion
NM_015329.4 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.77
Genes affected
MAU2 (HGNC:29140): (MAU2 sister chromatid cohesion factor) Enables protein N-terminus binding activity. Involved in cohesin loading and maintenance of mitotic sister chromatid cohesion. Located in chromatin and nuclear body. Part of Scc2-Scc4 cohesin loading complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_015329.4.
BP6
Variant 19-19320880-AGCGGCCCAGGCGGCG-A is Benign according to our data. Variant chr19-19320880-AGCGGCCCAGGCGGCG-A is described in ClinVar as [Benign]. Clinvar id is 771929.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4_exome allele frequency = 0.0137 (18710/1364568) while in subpopulation NFE AF= 0.0155 (16507/1065808). AF 95% confidence interval is 0.0153. There are 151 homozygotes in gnomad4_exome. There are 9160 alleles in male gnomad4_exome subpopulation. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1420 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00938 AC: 1420AN: 151326Hom.: 16 Cov.: 33
GnomAD3 genomes
AF:
AC:
1420
AN:
151326
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0121 AC: 1496AN: 124134Hom.: 14 AF XY: 0.0121 AC XY: 839AN XY: 69120
GnomAD3 exomes
AF:
AC:
1496
AN:
124134
Hom.:
AF XY:
AC XY:
839
AN XY:
69120
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0137 AC: 18710AN: 1364568Hom.: 151 AF XY: 0.0136 AC XY: 9160AN XY: 674068
GnomAD4 exome
AF:
AC:
18710
AN:
1364568
Hom.:
AF XY:
AC XY:
9160
AN XY:
674068
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00938 AC: 1420AN: 151440Hom.: 16 Cov.: 33 AF XY: 0.00902 AC XY: 668AN XY: 74052
GnomAD4 genome
AF:
AC:
1420
AN:
151440
Hom.:
Cov.:
33
AF XY:
AC XY:
668
AN XY:
74052
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 09, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at